Researchers highlight the benefits of using both procedures in patients with glaucoma or ocular hypertension

Scottish researchers will explore whether the medications are effective in treating the genetic eye condition

The US Food and Drug Administration has approved the use of MiSight to slow the progression of myopia in children aged between eight and 12

An aqueous humour biopsy offers an opportunity to diagnose patients at a molecular level

Compressing visual data gathered by the device helps to prevent the electronics in the sight-restoring technology from becoming too hot

Applying eye drops that contain the protein VEGF188 has the potential to improve nerve regeneration in the cornea following injury

Fight for Sight-funded research identifies alternative treatment to antibiotics

Researchers have said that their findings “highlight the urgent need to raise awareness of the symptoms of macular disease”

Six patients with wet age-related macular degeneration have gone for six months without the need for regular injections

GenSight chief medical officer, Magali Taiel, talks to OT  about two pioneering approaches to treating inherited eye disease